head JofIMAB
Journal of IMAB - Annual Proceeding (Scientific Papers)
Publisher: Peytchinski Publishing
ISSN: 1312-773X (Online)
Issue: 2017, vol. 23, issue 2
Subject Area: Medicine
DOI: 10.5272/jimab.2017232.1603
Published online: 26 June 2017

Original article

J of IMAB 2017 Apr-Jun;23(2):1603-1606
Georgi Bonchev1ORCID logoCorresponding Autoremail, Snezha Zlateva1,2, Petko Marinov1,2, Ivaylo Vazharov3
1) Clinic for Intensive Treatment of Acute Intoxications and Toxicoallergies, Naval Hospital – Varna, Military Medical Academy, Bulgaria
2) Department of Pharmacology, Toxicology and Pharmacotherapy, Faculty of Pharmacy, Medical University – Varna, Bulgaria
3) Clinic of Internal Diseases, Naval Hospital – Varna, Military Medical Academy, Bulgaria.

Purpose: To develop a reliable method for qualitative determination of amphetamines in biological samples, that combines simplicity, sensitiveness and robustness. Optimization of the method should be carried out in order to meet the needs of forensic expertise as daily routine.
Material/Methods: Analytical identification was done by menas of gas chromatography – mass spectrometry. Validation was carried out using certified analytical standards.
Results: Sample preparation procedure has been simplified. Only common reagents are needed. Solid phase extraction (SPE) has been used for initial purification of biological samples. Additional derivatization (PFPA) has been shown to be of major importance. Limit of detection (LOD) in blood samples has been determined to be as low as 25 ng/mL for amphetamine (AMP) and 10 ng/mL for methamphetamine (MET). Results are given within 100 minutes.

Keywords: samphetamine, methamphetamine, solid phase extraction, analytical toxicology, drugs of abuse, forensic expertise,

pdf - Download FULL TEXT /PDF 656 KB/
Please cite this article in PubMed Style or AMA (American Medical Association) Style:
Bonchev G, Zlateva S, Marinov P, Vazharov I. An optimized GC-MS method for amphetamines identification. J of IMAB. 2017 Jan-Mar;23(2):1603-1606. doi: 10.5272/jimab.2017232.1603

Corresponding AutorCorrespondence to: Georgi Bonchev, PhD, Head, Laboratory of Analytical Toxicology, Military Medical Academy, Naval Hospital – Varna; 3, Hristo Smirnenski Blvd., 9010 Varna, Bulgaria; E-mail: toxilab.varna@abv.bg

1. Glennon RA. Phenylisopropylamine stimulants: amphetamine-related agents. In: Lemke TL, Williams DA, Roche VF, Zito W, editors. Foye’s principles of medicinal chemistry. 7th ed. Philadelphia, USA: Wolters Kluwer Health/Lippincott Williams & Wilkins. 2013. 646 p.
2.Hagel JM, Krizevski R, Marsolais F, Lewinsohn E, Facchini PJ. Biosynthesis of amphetamine analogs in plants. Trends Plant Sci. 2012 Jul;17(7):404–12. [PubMed]
3. United Nations Office on Drugs and Crime. Statistics: Drug use and health consequences. Vienna: UNONDC; 2017. [cited 2017 Mar 31] [Internet]
4. Schulz M, Iwersen-Bergmann S, Andresen H, Schmoldt A. Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics. Crit Care. 2012;16(4):R136. [PMC]
5.Clinical drug testing in primary care. Technical assistance publication series 32. United States Department of health and human services. Rockville: SAMHSA; 2012. [cited 2017 Apr 03] [Internet]
6. Dräger DrugCheck® 3000. Lubeck, Germany: Drдgerwerk AG & Co. KGaA. 2017. [cited 2017 Apr 03] [Internet]
7. Cody JT, Foltz RL. GC/MS analysis of body fluids for drugs of abuse. In: Yinon J, editor. Forensic applications of mass spectrometry. Florida: CRC Press; 1995. p. 2–59.
8. Hsu MC, Chen D, Liu RH. Detection of abused drugs in urine by GC-MS. J of Food and Drug Analysis. 2009;17(4):233-45. [Internet]
9. Villamor JL, Bermejo AM, Fernбndez P, Tabernero MJ. GC MS determination of amphetamines in human urine. Analytical Letters. 2005;38(5):781-90. [Internet]
10. Frison G, Tedeschi L, Favretto D, Reheman A, Ferrara SD. Gas chromatography/mass spectrometry determination of amphetamine-related drugs and ephedrines in plasma, urine and hair samples after derivatization with 2,2,2-trichloroethyl chloroformate. Rapid Commun Mass Spectrom. 2005;19(7):919-27. [PubMed]
11. Peters FT, Samyn N, Wahl M, Kraemer T, De Boeck G, Maurer HH. Concentrations and ratios of amphetamine, methamphetamine, MDA, MDMA, and MDEA enantiomers determined in plasma samples from clinical toxicology and driving under the influence of drugs cases by GC-NICI-MS. J Anal Toxicol. 2003 Nov-Dec;27(8):552-9. [PubMed]
12. NIST Mass Spectrometry Data Center. USA: U.S. Secretary of Commerce; 2016. [Internet]
13. Bonchev G. An optimized GC-MS method for identification of Cocaine and its major metabolites. J of IMAB. 2017 Apr-Jun;23(2):1523-6. [CrossRef]
14. Armbruster DA, Tillman MD, Hubbs LM. Limit of detection (LOD)/limit of quantitation (LOQ): comparison of the empirical and the statistical methods exemplified with GC-MS assays of abused drugs. Clin Chem. 40(7 Pt 1);1994:1233-8. [PubMed]
15. Lawson GM. Defining limit of detection and limit of quantitation as applied to drug of abuse testing: striving for a consensus. Clin Chem. 40(7 Pt 1);1994:1218-9. [PubMed].

Received: 03 April 2017
Published online: 26 June 2017

back to Online Journal